Regulation of the metabolism of polyunsaturated fatty acids and butyrate in colon cancer cells

Current Pharmaceutical Biotechnology

Volumn 14, Issue 3, 2013, Pages 274-288

  Hofmanová, Jiřina ^a   Vaculová, Alena Hyrs̀lová ^a   Kozubík, Alois ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

Author keywords

Butyrate; Cell signaling; Colon cancer; Cytokinetics; Dietary fatty acids; Eicosanoids; Polyunsaturated fatty acids

Indexed keywords

BUTYRIC ACID; CYTOCHROME P450; DIAZEPAM BINDING INHIBITOR; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; ICOSANOID; IRINOTECAN; LIPOXYGENASE; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; SHORT CHAIN FATTY ACID; STEROL CARRIER PROTEIN 2; SYNAPTOPHYSIN; TAMOXIFEN;

AEROBIC METABOLISM; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; BIOLOGICAL ACTIVITY; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CELL ADHESION; CELL DEATH; CELL DIFFERENTIATION; CELL INVASION; CELL KINETICS; CELL METABOLISM; CELL PROLIFERATION; CELL STRUCTURE; COLON CANCER; ENTERITIS; FATTY ACID SYNTHESIS; GASTROINTESTINAL TUMOR; GENE EXPRESSION; HEALTH CARE POLICY; HUMAN; HYPERTHERMIA; INFLAMMATION; METABOLIC REGULATION; NEOPLASM; NONHUMAN; OBESITY; PHOTODYNAMIC THERAPY; RADIATION; RECURRENT DISEASE; SIGNAL TRANSDUCTION;

ANIMALS; BUTYRATES; COLONIC NEOPLASMS; FATTY ACIDS, UNSATURATED; HUMANS; LIPID METABOLISM;

EID: 84875356074     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201011314030004     Document Type: Article

References (195)

1. Ahmed, F.E. Colon cancer: prevalence, screening, gene expression and mutation, and risk factors and assessment. J. Environ. Sci. Health C Environ. Carcinog Ecotoxicol. Rev., 2003, 21(2), 65-131.
2. Yang, K.; Yang, W.; Mariadason, J.; Velcich, A.; Lipkin, M.; Augenlicht, L. Dietary components modify gene expression: implications for carcinogenesis. J. Nutr., 2005, 135(11), 2710-2714.
3. Chapkin, R.S.; Hong, M.Y.; Fan, Y.Y.; Davidson, L.A.; Sanders, L.M.; Henderson, C.E.; Barhoumi, R.; Burghardt, R.C.; Turner, N.D.; Lupton, J.R. Dietary n-3 PUFA alter colonocyte mitochondrial membrane composition and function. Lipids, 2002, 37(2), 193-199.
4. Andoh, A.; Tsujikawa, T.; Fujiyama, Y. Role of dietary fiber and short-chain fatty acids in the colon. Curr. Pharm. Des., 2003, 9(4), 347-58.
5. Reddy, B.S. Dietary fat and colon cancer: animal model studies. Lipids, 1992, 27(10), 807-813.
6. Boudreau, M.D.; Sohn, K.H.; Rhee, S.H.; Lee, S.W.; Hunt, J.D.; Hwang, D.H. Suppression of tumor cell growth both in nude mice and in culture by n-3 polyunsaturated fatty acids: mediation through cyclooxygenase-independent pathways. Cancer Res., 2001, 61(4), 1386-1391.
7. Calder, P.C. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol. Nutr. Food Res., 2008, 52(8), 885-897.
8. Kim, W.; McMurray, D.N.; Chapkin, R.S. Chemotherapeutic Properties of n-3 Polyunsaturated Fatty Acids - Old Concepts and New Insights. Immunol. Endocr. Metab. Agents Med. Chem., 2009, 9(1), 38-44.
9. Pauwels, E.K.; Kairemo, K. Fatty acid facts, part II: role in the prevention of carcinogenesis, or, more fish on the dish? Drug News Perspect., 2008, 21(9), 504-510.
10. Diggle, C.P. In vitro studies on the relationship between polyunsaturated fatty acids and cancer: tumour or tissue specific effects? Prog. Lipid Res., 2002, 41(3), 240-253.
11. Lupton, J.R. Microbial degradation products influence colon cancer risk: the butyrate controversy. J. Nutr., 2004, 134(2), 479-482.
12. Chapkin, R.S.; Seo, J.; McMurray, D.N.; Lupton, J.R. Mechanisms by which docosahexaenoic acid and related fatty acids reduce colon cancer risk and inflammatory disorders of the intestine. Chem. Phys. Lipids, 2008, 153(1), 14-23.
13. Hofmanova, J.; Vaculova, A.; Lojek, A.; Kozubik, A. Interaction of polyunsaturated fatty acids and sodium butyrate during apoptosis in HT-29 human colon adenocarcinoma cells. Eur. J. Nutr., 2005, 44(1), 40-51.
14. Hofmanova, J.; Vaculova, A.; Koubkova, Z.; Hyzd'alova, M.; Kozubik, A. Human fetal colon cells and colon cancer cells respond differently to butyrate and PUFAs. Mol. Nutr. Food Res., 2009, 53 (Suppl 1), S102-13.
15. Hofmanova, J.; Vaculova, A.; Kozubik, A. Polyunsaturated fatty acids sensitize human colon adenocarcinoma HT-29 cells to death receptor-mediated apoptosis. Cancer Lett., 2005, 218(1), 33-41.
16. Vaculova, A.; Hofmanova, J.; Andera, L.; Kozubik, A. TRAIL and docosahexaenoic acid cooperate to induce HT-29 colon cancer cell death. Cancer Lett., 2005, 229(1), 43-48.
17. Hyzd'alova, M.; Hofmanova, J.; Pachernik, J.; Vaculova, A.; Kozubik, A. The interaction of butyrate with TNF-alpha during differentiation and apoptosis of colon epithelial cells: role of NF-kappaB activation. Cytokine, 2008, 44(1), 33-43.
18. Conklin, K.A. Dietary polyunsaturated fatty acids: impact on cancer chemotherapy and radiation. Altern Med. Rev., 2002, 7(1), 4-21.
19. Dupertuis, Y.M.; Meguid, M.M.; Pichard, C. Colon cancer therapy: new perspectives of nutritional manipulations using polyunsaturated fatty acids. Curr. Opin. Clin. Nutr. Metab. Care, 2007, 10(4), 427-432.
20. Zhang, J.; Wu, G.; Chapkin, R.S.; Lupton, J.R. Energy metabolism of rat colonocytes changes during the tumorigenic process and is dependent on diet and carcinogen. J. Nutr., 1998, 128(8), 1262-1269.
21. Gee, J.M.; Watson, M.; Matthew, J.A.; Rhodes, M.; Speakman, C.J.; Stebbings, W.S.; Johnson, I.T. Consumption of fish oil leads to prompt incorporation of eicosapentaenoic acid into colonic mucosa of patients prior to surgery for colorectal cancer, but has no detectable effect on epithelial cytokinetics. J. Nutr., 1999, 129(10), 1862-1865.
22. Beaslas, O.; Torreilles, F.; Casellas, P.; Simon, D.; Fabre, G.; Lacasa, M.; Delers, F.; Chambaz, J.; Rousset, M.; Carriere, V. Transcriptome response of enterocytes to dietary lipids: impact on cell architecture, signaling, and metabolism genes. Am. J. Physiol. Gastrointest. Liver Physiol., 2008, 295(5), G942-952.
23. Heimerl, S.; Moehle, C.; Zahn, A.; Boettcher, A.; Stremmel, W.; Langmann, T.; Schmitz, G. Alterations in intestinal fatty acid metabolism in inflammatory bowel disease. Biochim. Biophys. Acta, 2006, 1762(3), 341-350.
24. Dobrzynska, I.; Szachowicz-Petelska, B.; Sulkowski, S.; Figaszewski, Z. Changes in electric charge and phospholipids composition in human colorectal cancer cells. Mol. Cell Biochem., 2005, 276(1-2), 113-119.
25. Shimma, S.; Sugiura, Y.; Hayasaka, T.; Hoshikawa, Y.; Noda, T.; Setou, M. MALDI-based imaging mass spectrometry revealed abnormal distribution of phospholipids in colon cancer liver metastasis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2007, 855(1), 98-103.
26. Rakheja, D.; Kapur, P.; Hoang, M.P.; Roy, L.C.; Bennett, M.J. Increased ratio of saturated to unsaturated C18 fatty acids in colonic adenocarcinoma: implications for cryotherapy and lipid raft function. Med. Hypotheses, 2005, 65(6), 1120-1123.
27. Das, U. A radical approach to cancer. Med. Sci. Monit., 2002, 8(4), RA79-92.
28. Ho, S.Y.; Storch, J. Common mechanisms of monoacylglycerol and fatty acid uptake by human intestinal Caco-2 cells. Am. J. Physiol. Cell Physiol., 2001, 281(4), C1106-1117.
29. Bonen, A.; Campbell, S.E.; Benton, C.R.; Chabowski, A.; Coort, S.L.; Han, X.X.; Koonen, D.P.; Glatz, J.F.; Luiken, J.J. Regulation of fatty acid transport by fatty acid translocase/CD36. Proc. Nutr. Soc., 2004, 63(2), 245-249.
30. Schonberg, S.A.; Lundemo, A.G.; Fladvad, T.; Holmgren, K.; Bremseth, H.; Nilsen, A.; Gederaas, O.; Tvedt, K.E.; Egeberg, K.W.; Krokan, H.E. Closely related colon cancer cell lines display different sensitivity to polyunsaturated fatty acids, accumulate different lipid classes and downregulate sterol regulatory elementbinding protein 1. FEBS. J., 2006, 273(12), 2749-2765.
31. Escrich, E.; Moral, R.; Grau, L.; Costa, I.; Solanas, M. Molecular mechanisms of the effects of olive oil and other dietary lipids on cancer. Mol. Nutr. Food Res., 2007, 51(10), 1279-1292.
32. Reynier, M.; Sari, H.; d'Anglebermes, M.; Kye, E.A.; Pasero, L. Differences in lipid characteristics of undifferentiated and enterocytic- differentiated HT29 human colonic cells. Cancer Res., 1991, 51(4), 1270-1277.
33. Levy, E.; Yotov, W.; Seidman, E.G.; Garofalo, C.; Delvin, E.; Menard, D. Caco-2 cells and human fetal colon: a comparative analysis of their lipid transport. Biochim. Biophys. Acta, 1999, 1439(3), 353-362.
34. Surette, M.E.; Winkler, J.D.; Fonteh, A.N.; Chilton, F.H. Relationship between arachidonate--phospholipid remodeling and apoptosis. Biochemistry, 1996, 35(28), 9187-9196.
35. Laurenz, J.C.; Gunn, J.M.; Jolly, C.A.; Chapkin, R.S. Alteration of glycerolipid and sphingolipid-derived second messenger kinetics in ras transformed 3T3 cells. Biochim. Biophys. Acta, 1996, 1299(1), 146-154.
36. Calviello, G.; Palozza, P.; Maggiano, N.; Piccioni, E.; Franceschelli, P.; Frattucci, A.; Di Nicuolo, F.; Bartoli, G.M. Cell proliferation, differentiation, and apoptosis are modified by n-3 polyunsaturated fatty acids in normal colonic mucosa. Lipids, 1999, 34(6), 599-604.
37. Senkal, M.; Haaker, R.; Linseisen, J.; Wolfram, G.; Homann, H.H.; Stehle, P. Preoperative oral supplementation with long-chain Omega-3 fatty acids beneficially alters phospholipid fatty acid patterns in liver, gut mucosa, and tumor tissue. JPEN J. Parenter Enteral Nutr., 2005, 29(4), 236-240.
38. Anti, M.; Armelao, F.; Marra, G.; Percesepe, A.; Bartoli, G.M.; Palozza, P.; Parrella, P.; Canetta, C.; Gentiloni, N.; De Vitis, I. Effects of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomas. Gastroenterology, 1994, 107(6), 1709-1718.
39. Pot, G.K.; Geelen, A.; van Heijningen, E.M.; Siezen, C.L.; van Kranen, H.J.; Kampman, E. Opposing associations of serum n-3 and n-6 polyunsaturated fatty acids with colorectal adenoma risk: an endoscopy-based case-control study. Int. J. Cancer, 2008, 123(8), 1974-1977.
40. Nkondjock, A.; Shatenstein, B.; Maisonneuve, P.; Ghadirian, P. Specific fatty acids and human colorectal cancer: an overview. Cancer Detect. Prev., 2003, 27(1), 55-66.
41. Roynette, C.E.; Calder, P.C.; Dupertuis, Y.M.; Pichard, C. n-3 polyunsaturated fatty acids and colon cancer prevention. Clin. Nutr., 2004, 23(2), 139-151.
42. Calviello, G.; Serini, S.; Piccioni, E. n-3 polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involved. Curr. Med. Chem., 2007, 14(29), 3059-3069.
43. MacLean, C.H.; Newberry, S.J.; Mojica, W.A.; Khanna, P.; Issa, A.M.; Suttorp, M.J.; Lim, Y.W.; Traina, S.B.; Hilton, L.; Garland, R.; Morton, S.C. Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA, 2006, 295(4), 403-415.
44. Sprecher, H. The roles of anabolic and catabolic reactions in the synthesis and recycling of polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids, 2002, 67(2-3), 79-83.
45. Stahl, A.; Gimeno, R.E.; Tartaglia, L.A.; Lodish, H.F. Fatty acid transport proteins: a current view of a growing family. Trends Endocrinol. Metab., 2001, 12(6), 266-273.
46. Sandoval, A.; Fraisl, P.; Arias-Barrau, E.; Dirusso, C.C.; Singer, D.; Sealls, W.; Black, P.N. Fatty acid transport and activation and the expression patterns of genes involved in fatty acid trafficking. Arch. Biochem. Biophys., 2008, 477(2), 363-371.
47. Anderson, B.M.; Ma, D.W. Are all n-3 polyunsaturated fatty acids created equal? Lipids Health Dis., 2009, 8, 33.
48. Simopoulos, A.P. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed. Pharmacother., 2002, 56(8), 365-379.
49. Los, D.A.; Murata, N. Membrane fluidity and its roles in the perception of environmental signals. Biochim. Biophys. Acta, 2004, 1666(1-2), 142-157.
50. Spector, A.A.; Yorek, M.A. Membrane lipid composition and cellular function. J. Lipid Res., 1985, 26(9), 1015-1035.
51. Rudolph, I.L.; Kelley, D.S.; Klasing, K.C.; Erickson, K.L. Regulation of cellular differentiation and apoptosis by fatty acids and their metabolites. Nutr. Res., 2001, 21(1-2), 381-393.
52. Moyad, M.A. An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: part II. Urol Oncol., 2005, 23(1), 36-48.
53. Rose, D.P.; Connolly, J.M. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol. Ther., 1999, 83(3), 217-244.
54. Tapiero, H.; Ba, G.N.; Couvreur, P.; Tew, K.D. Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. Biomed. Pharmacother., 2002, 56(5), 215-222.
55. Wanten, G.J.; Calder, P.C. Immune modulation by parenteral lipid emulsions. Am. J. Clin. Nutr., 2007, 85(5), 1171-1184.
56. Berquin, I.M.; Edwards, I.J.; Chen, Y.Q. Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett., 2008, 269(2), 363-377.
57. Pardini, R.S. Nutritional intervention with omega-3 fatty acids enhances tumor response to anti-neoplastic agents. Chem. Biol. Interact., 2006, 162(2), 89-105.
58. Engelbrecht, A.M.; Toit-Kohn, J.L.; Ellis, B.; Thomas, M.; Nell, T.; Smith, R. Differential induction of apoptosis and inhibition of the PI3-kinase pathway by saturated, monounsaturated and polyunsaturated fatty acids in a colon cancer cell model. Apoptosis, 2008, 13(11), 1368-1377.
59. Habermann, N.; Christian, B.; Luckas, B.; Pool-Zobel, B.L.; Lund, E.K.; Glei, M. Effects of fatty acids on metabolism and cell growth of human colon cell lines of different transformation state. Biofactors, 2009, 35(5), 460-467.
60. Soucek, K.; Gajduskova, P.; Brazdova, M.; Hyzd'alova, M.; Koci, L.; Vydra, D.; Trojanec, R.; Pernicova, Z.; Lentvorska, L.; Hajduch, M.; Hofmanova, J.; Kozubik, A. Fetal colon cell line FHC exhibits tumorigenic phenotype, complex karyotype, and TP53 gene mutation. Cancer Genet. Cytogenet., 2010, 197(2), 107-116.
61. Glatz, J.F.; Luiken, J.J.; Bonen, A. Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol. Rev., 2010, 90(1), 367-417.
62. Stillwell, W.; Shaikh, S.R.; Zerouga, M.; Siddiqui, R.; Wassall, S.R. Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reprod. Nutr. Dev., 2005, 45(5), 559-579.
63. Remacle-Bonnet, M.; Garrouste, F.; Baillat, G.; Andre, F.; Marvaldi, J.; Pommier, G. Membrane rafts segregate pro- from antiapoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily. Am. J. Pathol., 2005, 167(3), 761-773.
64. Pohl, J.; Ring, A.; Ehehalt, R.; Herrmann, T.; Stremmel, W. New concepts of cellular fatty acid uptake: role of fatty acid transport proteins and of caveolae. Proc. Nutr. Soc., 2004, 63(2), 259-262.
65. Benton, C.R.; Holloway, G.P.; Campbell, S.E.; Yoshida, Y.; Tandon, N.N.; Glatz, J.F.; Luiken, J.J.; Spriet, L.L.; Bonen, A. Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria. J. Physiol., 2008, 586(6), 1755-1766.
66. Drover, V.A.; Nguyen, D.V.; Bastie, C.C.; Darlington, Y.F.; Abumrad, N.A.; Pessin, J.E.; London, E.; Sahoo, D.; Phillips, M.C. CD36 mediates both cellular uptake of very long chain fatty acids and their intestinal absorption in mice. J. Biol. Chem., 2008, 283(19), 13108-13115.
67. Soupene, E.; Kuypers, F.A. Mammalian long-chain acyl-CoA synthetases. Exp. Biol. Med. (Maywood), 2008, 233(5), 507-521.
68. Gassler, N.; Herr, I.; Schneider, A.; Penzel, R.; Langbein, L.; Schirmacher, P.; Kopitz, J. Impaired expression of acyl-CoA synthetase 5 in sporadic colorectal adenocarcinomas. J. Pathol., 2005, 207(3), 295-300.
69. Knudsen, J.; Neergaard, T.B.; Gaigg, B.; Jensen, M.V.; Hansen, J.K. Role of acyl-CoA binding protein in acyl-CoA metabolism and acyl-CoA-mediated cell signaling. J. Nutr., 2000, 130(2S Suppl), 294S-298S.
70. Gossett, R.E.; Frolov, A.A.; Roths, J.B.; Behnke, W.D.; Kier, A.B.; Schroeder, F. Acyl-CoA binding proteins: multiplicity and function. Lipids, 1996, 31(9), 895-918.
71. Davidson, N.O.; Ifkovits, C.A.; Skarosi, S.F.; Hausman, A.M.; Llor, X.; Sitrin, M.D.; Montag, A.; Brasitus, T.A. Tissue and cellspecific patterns of expression of rat liver and intestinal fatty acid binding protein during development and in experimental colonic and small intestinal adenocarcinomas. Lab. Invest., 1993, 68(6), 663-675.
72. Levy, E.; Menard, D.; Delvin, E.; Montoudis, A.; Beaulieu, J.F.; Mailhot, G.; Dube, N.; Sinnett, D.; Seidman, E.; Bendayan, M. Localization, function and regulation of the two intestinal fatty acidbinding protein types. Histochem. Cell Biol., 2009, 132(3), 351-367.
73. Bozza, P.T.; Magalhaes, K.G.; Weller, P.F. Leukocyte lipid bodies - Biogenesis and functions in inflammation. Biochim Biophys Acta, 2009, 1791(6), 540-551.
74. Ducharme, N.A.; Bickel, P.E. Lipid droplets in lipogenesis and lipolysis. Endocrinology, 2008, 149(3), 942-9.
75. Finstad, H.S.; Drevon, C.A.; Kulseth, M.A.; Synstad, A.V.; Knudsen, E.; Kolset, S.O. Cell proliferation, apoptosis and accumulation of lipid droplets in U937-1 cells incubated with eicosapentaenoic acid. Biochem. J., 1998, 336 (Pt 2), 451-9.
76. Accioly, M.T.; Pacheco, P.; Maya-Monteiro, C.M.; Carrossini, N.; Robbs, B.K.; Oliveira, S.S.; Kaufmann, C.; Morgado-Diaz, J.A.; Bozza, P.T.; Viola, J.P. Lipid bodies are reservoirs of cyclooxygenase- 2 and sites of prostaglandin-E2 synthesis in colon cancer cells. Cancer Res., 2008, 68(6), 1732-40.
77. Moreira, L.S.; Piva, B.; Gentile, L.B.; Mesquita-Santos, F.P.; D'Avila, H.; Maya-Monteiro, C.M.; Bozza, P.T.; Bandeira-Melo, C.; Diaz, B.L. Cytosolic phospholipase A2-driven PGE2 synthesis within unsaturated fatty acids-induced lipid bodies of epithelial cells. Biochim. Biophys. Acta., 2009, 1791(3), 156-65.
78. Cohen, A.W.; Razani, B.; Schubert, W.; Williams, T.M.; Wang, X.B.; Iyengar, P.; Brasaemle, D.L.; Scherer, P.E.; Lisanti, M.P. Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes, 2004, 53(5), 1261-70.
79. Bender, F.C.; Reymond, M.A.; Bron, C.; Quest, A.F. Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res., 2000, 60(20), 5870-8.
80. Kim, H.A.; Kim, K.H.; Lee, R.A. Expression of caveolin-1 is correlated with Akt-1 in colorectal cancer tissues. Exp. Mol. Pathol., 2006, 80(2), 165-70.
81. Menendez, J.A.; Lupu, R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer, 2007, 7(10), 763-77.
82. Medes, G.; Thomas, A.; Weinhouse, S. Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res., 1953, 13(1), 27-29.
83. Kuhajda, F.P.; Jenner, K.; Wood, F.D.; Hennigar, R.A.; Jacobs, L.B.; Dick, J.D.; Pasternack, G.R. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc. Natl. Acad Sci. USA, 1994, 91(14), 6379-83.
84. Visca, P.; Alo, P.L.; Del Nonno, F.; Botti, C.; Trombetta, G.; Marandino, F.; Filippi, S.; Di Tondo, U.; Donnorso, R.P. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa. Clin. Cancer Res., 1999, 5(12), 4111-8.
85. Wang, H.Q.; Altomare, D.A.; Skele, K.L.; Poulikakos, P.I.; Kuhajda, F.P.; Di Cristofano, A.; Testa, J.R. Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells. Oncogene, 2005, 24(22), 3574-82.
86. Menendez, J.A.; Lupu, R. Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells. Curr. Opin. Clin. Nutr. Metab. Care, 2006, 9(4), 346-57.
87. Nomura, D.K.; Long, J.Z.; Niessen, S.; Hoover, H.S.; Ng, S.W.; Cravatt, B.F. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell, 2010, 140(1), 49-61.
88. Schaeffer, L.; Gohlke, H.; Muller, M.; Heid, I.M.; Palmer, L.J.; Kompauer, I.; Demmelmair, H.; Illig, T.; Koletzko, B.; Heinrich, J. Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum. Mol. Genet., 2006, 15(11), 1745-56.
89. Furstenberger, G.; Krieg, P.; Muller-Decker, K.; Habenicht, A.J. What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis? Int. J. Cancer, 2006, 119(10), 2247-54.
90. Wada, M.; DeLong, C.J.; Hong, Y.H.; Rieke, C.J.; Song, I.; Sidhu, R.S.; Yuan, C.; Warnock, M.; Schmaier, A.H.; Yokoyama, C.; Smyth, E.M.; Wilson, S.J.; FitzGerald, G.A.; Garavito, R.M.; Sui de, X.; Regan, J.W.; Smith, W.L. Enzymes and receptors of prosta glandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J. Biol. Chem., 2007, 282(31), 22254-66.
91. Soberman, R.J.; Christmas, P. The organization and consequences of eicosanoid signaling. J. Clin. Invest., 2003, 111(8), 1107-13.
92. Dommels, Y.E.; Haring, M.M.; Keestra, N.G.; Alink, G.M.; van Bladeren, P.J.; van Ommen, B. The role of cyclooxygenase in n-6 and n-3 polyunsaturated fatty acid mediated effects on cell proliferation, PGE(2) synthesis and cytotoxicity in human colorectal carcinoma cell lines. Carcinogenesis, 2003, 24(3), 385-92.
93. West, J.D.; Marnett, L.J. Alterations in gene expression induced by the lipid peroxidation product, 4-hydroxy-2-nonenal. Chem. Res. Toxicol., 2005, 18(11), 1642-53.
94. Vogel, C. Prostaglandin H synthases and their importance in chemical toxicity. Curr Drug Metab., 2000, 1(4), 391-404.
95. Eberhart, C.E.; Coffey, R.J.; Radhika, A.; Giardiello, F.M.; Ferrenbach, S.; DuBois, R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 1994, 107(4), 1183-8.
96. Wang, D.; Dubois, R.N. The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene, 2010, 29(6), 781-8.
97. Simopoulos, A.P. Commentary. Genetic variants and omega-6, omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk. J Nutrigenet. Nutrigenomics, 2009, 2(3), 117-8.
98. Flachs, P.; Rossmeisl, M.; Bryhn, M.; Kopecky, J. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clin. Sci. (Lond), 2009, 116(1), 1-16.
99. Serhan, C.N.; Chiang, N. Endogenous pro-resolving and antiinflammatory lipid mediators: a new pharmacologic genus. Br. J. Pharmacol., 2008, 153 (Suppl) 1, S200-15.
100. Hofmanová, J.; Součk, K.; Vaculová, A.; Kozubík, A. Fatty acids in the modulation of reactive oxygen species balance in cancer. In: Oxidants in Biology: a question of balance." Springer Science and Business media B. V. Eds. G. Valacchi and P. A. Davis, 2008, 129-153.
101. Boonstra, J.; Post, J.A. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene., 2004, 337, 1-13.
102. Begin, M.E. Effects of polyunsaturated fatty acids and of their oxidation products on cell survival. Chem. Phys. Lipids, 1987, 45(2-4), 269-313.
103. Ott, M.; Gogvadze, V.; Orrenius, S.; Zhivotovsky, B. Mitochondria, oxidative stress and cell death. Apoptosis, 2007, 12(5), 913-22.
104. Stillwell, W.; Jenski, L.J.; Crump, F.T.; Ehringer, W. Effect of docosahexaenoic acid on mouse mitochondrial membrane properties. Lipids, 1997, 32(5), 497-506.
105. Di Paola, M.; Lorusso, M. Interaction of free fatty acids with mitochondria: coupling, uncoupling and permeability transition. Biochim. Biophys. Acta, 2006, 1757(9-10), 1330-7.
106. Cristea, I.M.; Degli Esposti, M. Membrane lipids and cell death: an overview. Chem. Phys. Lipids, 2004, 129(2), 133-160.
107. Hong, M.Y.; Chapkin, R.S.; Barhoumi, R.; Burghardt, R.C.; Turner, N.D.; Henderson, C.E.; Sanders, L.M.; Fan, Y.Y.; Davidson, L.A.; Murphy, M.E.; Spinka, C.M.; Carroll, R.J.; Lupton, J.R. Fish oil increases mitochondrial phospholipid unsaturation, upregulating reactive oxygen species and apoptosis in rat colonocytes. Carcinogenesis, 2002, 23(11), 1919-1925.
108. Ng, Y.; Barhoumi, R.; Tjalkens, R.B.; Fan, Y.Y.; Kolar, S.; Wang, N.; Lupton, J.R.; Chapkin, R.S. The role of docosahexaenoic acid in mediating mitochondrial membrane lipid oxidation and apoptosis in colonocytes. Carcinogenesis, 2005, 26(11), 1914-1921.
109. Esposti, M.D.; Cristea, I.M.; Gaskell, S.J.; Nakao, Y.; Dive, C. Proapoptotic Bid binds to monolysocardiolipin, a new molecular connection between mitochondrial membranes and cell death. Cell Death Differ., 2003, 10(12), 1300-1309.
110. Toit-Kohn, J.L.; Louw, L.; Engelbrecht, A.M. Docosahexaenoic acid induces apoptosis in colorectal carcinoma cells by modulating the PI3 kinase and p38 MAPK pathways. J. Nutr. Biochem., 2009, 20(2), 106-114.
111. Narayanan, B.A.; Narayanan, N.K.; Reddy, B.S. Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells. Int. J. Oncol., 2001, 19(6), 1255-1262.
112. Habermann, N.; Lund, E.K.; Pool-Zobel, B.L.; Glei, M. Modulation of gene expression in eicosapentaenoic acid and docosahexaenoic acid treated human colon adenoma cells. Genes Nutr., 2009, 4(1), 73-76.
113. Calviello, G.; Di Nicuolo, F.; Gragnoli, S.; Piccioni, E.; Serini, S.; Maggiano, N.; Tringali, G.; Navarra, P.; Ranelletti, F.O.; Palozza, P. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. Carcinogenesis, 2004, 25(12), 2303-2310.
114. Pegorier, J.P.; Le May, C.; Girard, J. Control of gene expression by fatty acids. J. Nutr., 2004, 134(9), 2444S-2449S.
115. Sampath, H.; Ntambi, J.M. Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu. Rev. Nutr., 2005, 25, 317-340.
116. Ponferrada, A.; Caso, J.R.; Alou, L.; Colon, A.; Sevillano, D.; Moro, M.A.; Lizasoain, I.; Menchen, P.; Gomez-Lus, M.L.; Lorenzo, P.; Cos, E.; Leza, J.C.; Menchen, L. The role of PPARgamma on restoration of colonic homeostasis after experimental stress-induced inflammation and dysfunction. Gastroenterology, 2007, 132(5), 1791-1803.
117. DuBois, R.N.; Gupta, R.; Brockman, J.; Reddy, B.S.; Krakow, S.L.; Lazar, M.A. The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers. Carcinogenesis, 1998, 19(1), 49-53.
118. Lin, M.S.; Chen, W.C.; Bai, X.; Wang, Y.D. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer. J. Dig. Dis., 2007, 8(2), 82-88.
119. Burgermeister, E.; Tencer, L.; Liscovitch, M. Peroxisome proliferator- activated receptor-gamma upregulates caveolin-1 and caveolin- 2 expression in human carcinoma cells. Oncogene, 2003, 22(25), 3888-3900.
120. Singer, P.; Shapiro, H.; Theilla, M.; Anbar, R.; Singer, J.; Cohen, J. Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective. Intensive Care Med., 2008, 34(9), 1580-1592.
121. Yang, W.L.; Frucht, H. Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells. Carcinogenesis, 2001, 22(9), 1379-1383.
122. Wang, Q.; Herrera-Ruiz, D.; Mathis, A.S.; Cook, T.J.; Bhardwaj, R.K.; Knipp, G.T. Expression of PPAR, RXR isoforms and fatty acid transporting proteins in the rat and human gastrointestinal tracts. J. Pharm. Sci., 2005, 94(2), 363-372.
123. Hamer, H.M.; Jonkers, D.; Venema, K.; Vanhoutvin, S.; Troost, F.J.; Brummer, R.J. Review article: the role of butyrate on colonic function. Aliment Pharmacol. Ther., 2008, 27(2), 104-119.
124. Thibault, R.; Blachier, F.; Darcy-Vrillon, B.; de Coppet, P.; Bourreille, A.; Segain, J.P. Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency. Inflamm. Bowel. Dis., 2010, 16(4), 684-695.
125. Andriamihaja, M.; Chaumontet, C.; Tome, D.; Blachier, F. Butyrate metabolism in human colon carcinoma cells: implications concerning its growth-inhibitory effect. J. Cell Physiol., 2009, 218(1), 58-65.
126. Lambert, D.W.; Wood, I.S.; Ellis, A.; Shirazi-Beechey, S.P. Molecular changes in the expression of human colonic nutrient transporters during the transition from normality to malignancy. Br. J. Cancer, 2002, 86(8), 1262-1269.
127. Cuff, M.A.; Lambert, D.W.; Shirazi-Beechey, S.P. Substrateinduced regulation of the human colonic monocarboxylate transporter, MCT1. J. Physiol., 2002, 539(Pt 2), 361-371.
128. Borthakur, A.; Saksena, S.; Gill, R.K.; Alrefai, W.A.; Ramaswamy, K.; Dudeja, P.K. Regulation of monocarboxylate transporter 1 (MCT1) promoter by butyrate in human intestinal epithelial cells: involvement of NF-kappaB pathway. J. Cell Biochem., 2008, 103(5), 1452-1463.
129. Cuff, M.; Dyer, J.; Jones, M.; Shirazi-Beechey, S. The human colonic monocarboxylate transporter Isoform 1: its potential importance to colonic tissue homeostasis. Gastroenterology, 2005, 128(3), 676-686.
130. Miyauchi, S.; Gopal, E.; Fei, Y.J.; Ganapathy, V. Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na(+)-coupled transporter for short-chain fatty acids. J. Biol. Chem., 2004, 279(14), 13293-13296.
131. Paroder, V.; Spencer, S.R.; Paroder, M.; Arango, D.; Schwartz, S., Jr.; Mariadason, J.M.; Augenlicht, L.H.; Eskandari, S.; Carrasco, N. Na(+)/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: molecular characterization of SMCT. Proc. Natl. Acad Sci. USA, 2006, 103(19), 7270-7275.
132. Ganapathy, V.; Thangaraju, M.; Gopal, E.; Martin, P.M.; Itagaki, S.; Miyauchi, S.; Prasad, P.D. Sodium-coupled monocarboxylate transporters in normal tissues and in cancer. Aaps. J., 2008, 10(1), 193-199.
133. Brown, A.J.; Goldsworthy, S.M.; Barnes, A.A.; Eilert, M.M.; Tcheang, L.; Daniels, D.; Muir, A.I.; Wigglesworth, M.J.; Kinghorn, I.; Fraser, N.J.; Pike, N.B.; Strum, J.C.; Steplewski, K.M.; Murdock, P.R.; Holder, J.C.; Marshall, F.H.; Szekeres, P.G.; Wilson, S.; Ignar, D.M.; Foord, S.M.; Wise, A.; Dowell, S.J. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem., 2003, 278(13), 11312-11319.
134. Le Poul, E.; Loison, C.; Struyf, S.; Springael, J.Y.; Lannoy, V.; Decobecq, M.E.; Brezillon, S.; Dupriez, V.; Vassart, G.; Van Damme, J.; Parmentier, M.; Detheux, M. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J. Biol. Chem., 2003, 278(28), 25481-25489.
135. Tazoe, H.; Otomo, Y.; Karaki, S.; Kato, I.; Fukami, Y.; Terasaki, M.; Kuwahara, A. Expression of short-chain fatty acid receptor GPR41 in the human colon. Biomed. Res., 2009, 30(3), 149-156.
136. Dass, N.B.; John, A.K.; Bassil, A.K.; Crumbley, C.W.; Shehee, W.R.; Maurio, F.P.; Moore, G.B.; Taylor, C.M.; Sanger, G.J. The relationship between the effects of short-chain fatty acids on intestinal motility in vitro and GPR43 receptor activation. Neurogastroenterol. Motil., 2007, 19(1), 66-74.
137. Coradini, D.; Pellizzaro, C.; Marimpietri, D.; Abolafio, G.; Daidone, M.G. Sodium butyrate modulates cell cycle-related proteins in HT29 human colonic adenocarcinoma cells. Cell Prolif., 2000, 33(3), 139-146.
138. Nakano, K.; Mizuno, T.; Sowa, Y.; Orita, T.; Yoshino, T.; Okuyama, Y.; Fujita, T.; Ohtani-Fujita, N.; Matsukawa, Y.; Tokino, T.; Yamagishi, H.; Oka, T.; Nomura, H.; Sakai, T. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J. Biol. Chem., 1997, 272(35), 22199-22206.
139. Archer, S.; Meng, S.; Wu, J.; Johnson, J.; Tang, R.; Hodin, R. Butyrate inhibits colon carcinoma cell growth through two distinct pathways. Surgery, 1998, 124(2), 248-253.
140. Harrison, L.E.; Wang, Q.M.; Studzinski, G.P. Butyrate-induced G2/M block in Caco-2 colon cancer cells is associated with decreased p34cdc2 activity. Proc. Soc. Exp. Biol. Med., 1999, 222(2), 150-156.
141. Chopin, V.; Toillon, R.A.; Jouy, N.; Le Bourhis, X. P21(WAF1/CIP1) is dispensable for G1 arrest, but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells. Oncogene, 2004, 23(1), 21-29.
142. Cai, J.; Chen, Y.; Murphy, T.J.; Jones, D.P.; Sartorelli, A.C. Role of caspase activation in butyrate-induced terminal differentiation of HT29 colon carcinoma cells. Arch. Biochem. Biophys., 2004, 424(2), 119-127.
143. Gaschott, T.; Werz, O.; Steinmeyer, A.; Steinhilber, D.; Stein, J. Butyrate- induced differentiation of Caco-2 cells is mediated by vitamin D receptor. Biochem. Biophys. Res. Commun., 2001, 288(3), 690-696.
144. Pajak, B.; Orzechowski, A.; Gajkowska, B. Molecular basis of sodium butyrate-dependent proapoptotic activity in cancer cells. Adv. Med. Sci., 2007, 52, 83-88.
145. Ruemmele, F.M.; Dionne, S.; Qureshi, I.; Sarma, D.S.; Levy, E.; Seidman, E.G. Butyrate mediates Caco-2 cell apoptosis via upregulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP). Cell Death Differ., 1999, 6(8), 729-735.
146. Chirakkal, H.; Leech, S.H.; Brookes, K.E.; Prais, A.L.; Waby, J.S.; Corfe, B.M. Upregulation of BAK by butyrate in the colon is associated with increased Sp3 binding. Oncogene, 2006, 25(54), 7192-7200.
147. Mandal, M.; Wu, X.; Kumar, R. Bcl-2 deregulation leads to inhibition of sodium butyrate-induced apoptosis in human colorectal carcinoma cells. Carcinogenesis, 1997, 18(1), 229-232.
148. Pajak, B.; Gajkowska, B.; Orzechowski, A. Sodium butyrate sensitizes human colon adenocarcinoma COLO 205 cells to both intrinsic and TNF-alpha-dependent extrinsic apoptosis. Apoptosis, 2009, 14(2), 203-217.
149. Kim, Y.H.; Park, J.W.; Lee, J.Y.; Kwon, T.K. Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells. Carcinogenesis, 2004, 25(10), 1813-1820.
150. Hernandez, A.; Thomas, R.; Smith, F.; Sandberg, J.; Kim, S.; Chung, D.H.; Evers, B.M. Butyrate sensitizes human colon cancer cells to TRAIL-mediated apoptosis. Surgery, 2001, 130(2), 265-272.
151. Giardina, C.; Boulares, H.; Inan, M.S. NSAIDs and butyrate sensitize a human colorectal cancer cell line to TNF-alpha and Fas ligation: the role of reactive oxygen species. Biochim. Biophys. Acta, 1999, 1448(3), 425-438.
152. Chen, J.; Ghazawi, F.M.; Bakkar, W.; Li, Q. Valproic acid and butyrate induce apoptosis in human cancer cells through inhibition of gene expression of Akt/protein kinase B. Mol. Cancer, 2006, 5, 71.
153. Wang, Q.; Wang, X.; Hernandez, A.; Kim, S.; Evers, B.M. Inhibition of the phosphatidylinositol 3-kinase pathway contributes to HT29 and Caco-2 intestinal cell differentiation. Gastroenterology, 2001, 120(6), 1381-1392.
154. McMillan, L.; Butcher, S.K.; Pongracz, J.; Lord, J.M. Opposing effects of butyrate and bile acids on apoptosis of human colon adenoma cells: differential activation of PKC and MAP kinases. Br. J. Cancer, 2003, 88(5), 748-753.
155. Hinnebusch, B.F.; Meng, S.; Wu, J.T.; Archer, S.Y.; Hodin, R.A. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J. Nutr., 2002, 132(5), 1012-1017.
156. Quivy, V.; Van Lint, C. Regulation at multiple levels of NFkappaB- mediated transactivation by protein acetylation. Biochem. Pharmacol., 2004, 68(6), 1221-1229.
157. Inan, M.S.; Rasoulpour, R.J.; Yin, L.; Hubbard, A.K.; Rosenberg, D.W.; Giardina, C. The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. Gastroenterology, 2000, 118(4), 724-734.
158. Luhrs, H.; Kudlich, T.; Neumann, M.; Schauber, J.; Melcher, R.; Gostner, A.; Scheppach, W.; Menzel, T.P. Butyrate-enhanced TNFalpha-induced apoptosis is associated with inhibition of NFkappaB. Anticancer Res., 2002, 22(3), 1561-1568.
159. Schwab, M.; Reynders, V.; Ulrich, S.; Zahn, N.; Stein, J.; Schroder, O. PPARgamma is a key target of butyrate-induced caspase-3 activation in the colorectal cancer cell line Caco-2. Apoptosis, 2006, 11(10), 1801-1811.
160. Wachtershauser, A.; Loitsch, S.M.; Stein, J. PPAR-gamma is selectively upregulated in Caco-2 cells by butyrate. Biochem. Biophys. Res. Commun., 2000, 272(2), 380-385.
161. Joseph, J.; Mudduluru, G.; Antony, S.; Vashistha, S.; Ajitkumar, P.; Somasundaram, K. Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB. Oncogene, 2004, 23(37), 6304-6315.
162. Lee, J.C.; Maa, M.C.; Yu, H.S.; Wang, J.H.; Yen, C.K.; Wang, S.T.; Chen, Y.J.; Liu, Y.; Jin, Y.T.; Leu, T.H. Butyrate regulates the expression of c-Src and focal adhesion kinase and inhibits cell invasion of human colon cancer cells. Mol. Carcinog., 2005, 43(4), 207-214.
163. Barshishat, M.; Polak-Charcon, S.; Schwartz, B. Butyrate regulates E-cadherin transcription, isoform expression and intracellular position in colon cancer cells. Br. J. Cancer, 2000, 82(1), 195-203.
164. Pool-Zobel, B.L.; Selvaraju, V.; Sauer, J.; Kautenburger, T.; Kiefer, J.; Richter, K.K.; Soom, M.; Wolfl, S. Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione Stransferases genes, an approach in nutrigenomics. Carcinogenesis, 2005, 26(6), 1064-1076.
165. Louis, M.; Rosato, R.R.; Brault, L.; Osbild, S.; Battaglia, E.; Yang, X.H.; Grant, S.; Bagrel, D. The histone deacetylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stress. Int. J. Oncol., 2004, 25(6), 1701-1711.
166. Lee, D.Y.; Chapkin, R.S.; Lupton, J.R. Dietary fat and fiber modulate colonic cell proliferation in an interactive site-specific manner. Nutr. Cancer, 1993, 20(2), 107-118.
167. Chang, W.C.; Chapkin, R.S.; Lupton, J.R. Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis. Carcinogenesis, 1997, 18(4), 721-730.
168. Takahashi, M.; Totsuka, Y.; Masuda, M.; Fukuda, K.; Oguri, A.; Yazawa, K.; Sugimura, T.; Wakabayashi, K. Reduction in formation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)- induced aberrant crypt foci in the rat colon by docosahexaenoic acid (DHA). Carcinogenesis, 1997, 18(10), 1937-1941.
169. Seo, J.; Barhoumi, R.; Johnson, A.E.; Lupton, J.R.; Chapkin, R.S. Docosahexaenoic acid selectively inhibits plasma membrane targeting of lipidated proteins. Faseb J., 2006, 20(6), 770-772.
170. Ma, D.W. Lipid mediators in membrane rafts are important determinants of human health and disease. Appl. Physiol. Nutr. Metab., 2007, 32(3), 341-350.
171. Sanders, L.M.; Henderson, C.E.; Hong, M.Y.; Barhoumi, R.; Burghardt, R.C.; Wang, N.; Spinka, C.M.; Carroll, R.J.; Turner, N.D.; Chapkin, R.S.; Lupton, J.R. An increase in reactive oxygen species by dietary fish oil coupled with the attenuation of antioxidant defenses by dietary pectin enhances rat colonocyte apoptosis. J. Nutr., 2004, 134(12), 3233-3238.
172. Chapkin, R.S.; Gao, J.; Lee, D.Y.; Lupton, J.R. Dietary fibers and fats alter rat colon protein kinase C activity: correlation to cell proliferation. J. Nutr., 1993, 123(4), 649-655.
173. Jiang, Y.H.; Lupton, J.R.; Chang, W.C.; Jolly, C.A.; Aukema, H.M.; Chapkin, R.S. Dietary fat and fiber differentially alter intracellular second messengers during tumor development in rat colon. Carcinogenesis, 1996, 17(6), 1227-1233.
174. Fernandez-Banares, F.; Esteve, M.; Navarro, E.; Cabre, E.; Boix, J.; Abad-Lacruz, A.; Klaassen, J.; Planas, R.; Humbert, P.; Pastor, C.; Gassull, M.A. Changes of the mucosal n3 and n6 fatty acid status occur early in the colorectal adenoma-carcinoma sequence. Gut, 1996, 38(2), 254-259.
175. Hofmanova, J.; Zadak, Z.; Hyspler, R.; Mikeska, J.; Zdansky, P.; Vaculova, A.; Netikova, J.; Kozubik, A. The effects of parenteral lipid emulsions on cancer and normal human colon epithelial cells in vitro. Physiol. Res., 2005, 54(4), 409-418.
176. Zambell, K.L.; Fitch, M.D.; Fleming, S.E. Acetate and butyrate are the major substrates for de novo lipogenesis in rat colonic epithelial cells. J. Nutr., 2003, 133(11), 3509-3515.
177. Leschelle, X.; Delpal, S.; Goubern, M.; Blottiere, H.M.; Blachier, F. Butyrate metabolism upstream and downstream acetyl-CoA synthesis and growth control of human colon carcinoma cells. Eur. J. Biochem., 2000, 267(21), 6435-6442.
178. Awad, A.B.; Horvath, P.J.; Andersen, M.S. Influence of butyrate on lipid metabolism, survival, and differentiation of colon cancer cells. Nutr. Cancer, 1991, 16(2), 125-133.
179. Marcil, V.; Delvin, E.; Seidman, E.; Poitras, L.; Zoltowska, M.; Garofalo, C.; Levy, E. Modulation of lipid synthesis, apolipoprotein biogenesis, and lipoprotein assembly by butyrate. Am. J. Physiol. Gastrointest. Liver Physiol., 2002, 283(2), G340-346.
180. Yamane, M.; Yamane, S. The induction of colonocyte differentiation in CaCo-2 cells by sodium butyrate causes an increase in glucosylceramide synthesis in order to avoid apoptosis based on ceramide. Arch. Biochem. Biophys., 2007, 459(2), 159-168.
181. Gossett, R.E.; Schroeder, F.; Gunn, J.M.; Kier, A.B. Expression of fatty acyl-CoA binding proteins in colon cells: response to butyrate and transformation. Lipids, 1997, 32(6), 577-585.
182. Chapkin, R.S.; Clark, A.E.; Davidson, L.A.; Schroeder, F.; Zoran, D.L.; Lupton, J.R. Dietary fiber differentially alters cellular fatty acid-binding protein expression in exfoliated colonocytes during tumor development. Nutr. Cancer, 1998, 32(2), 107-112.
183. Kagan, V.E.; Tyurin, V.A.; Jiang, J.; Tyurina, Y.Y.; Ritov, V.B.; Amoscato, A.A.; Osipov, A.N.; Belikova, N.A.; Kapralov, A.A.; Kini, V.; Vlasova, II; Zhao, Q.; Zou, M.; Di, P.; Svistunenko, D.A.; Kurnikov, I.V.; Borisenko, G.G. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat. Chem. Biol., 2005, 1(4), 223-232.
184. Kolar, S.S.; Barhoumi, R.; Callaway, E.S.; Fan, Y.Y.; Wang, N.; Lupton, J.R.; Chapkin, R.S. Synergy between docosahexaenoic acid and butyrate elicits p53-independent apoptosis via mitochondrial Ca(2+) accumulation in colonocytes. Am. J. Physiol. Gastrointest. Liver Physiol., 2007, 293(5), G935-943.
185. Weylandt, K.H.; Kang, J.X. Rethinking lipid mediators. Lancet, 2005, 366(9486), 618-620.
186. Bougnoux, P.; Giraudeau, B.; Couet, C. Diet, cancer, and the lipidome. Cancer Epidemiol. Biomarkers Prev., 2006, 15(3), 416-421.
187. Hudert, C.A.; Weylandt, K.H.; Lu, Y.; Wang, J.; Hong, S.; Dignass, A.; Serhan, C.N.; Kang, J.X. Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc. Natl. Acad Sci. USA, 2006, 103(30), 11276-11281.
188. Xia, S.; Lu, Y.; Wang, J.; He, C.; Hong, S.; Serhan, C.N.; Kang, J.X. Melanoma growth is reduced in fat-1 transgenic mice: impact of omega-6/omega-3 essential fatty acids. Proc. Natl. Acad Sci. USA, 2006, 103(33), 12499-12504.
189. Chell, S.; Patsos, H.A.; Qualtrough, D.; AM, H.Z.; Hicks, D.J.; Kaidi, A.; Witherden, I.R.; Williams, A.C.; Paraskeva, C. Prospects in NSAID-derived chemoprevention of colorectal cancer. Biochem. Soc. Trans., 2005, 33(Pt 4), 667-671.
190. Cornwell, D.G.; Morisaki, N. Fatty Acid Paradoxes in the Control of Cell Proliferation: Prostaglandins, Lipid Peroxides, and Cooxidation Reactions. In: Free Radicals in Biology V, Ed. William A. Pryor, Academic Press. Inc., Academic Press. Inc. 1984, 95-133.
191. Kokura, S.; Nakagawa, S.; Hara, T.; Boku, Y.; Naito, Y.; Yoshida, N.; Yoshikawa, T. Enhancement of lipid peroxidation and of the antitumor effect of hyperthermia upon combination with oral eicosapentaenoic acid. Cancer Lett., 2002, 185(2), 139-144.
192. Norman, H.A.; Butrum, R.R.; Feldman, E.; Heber, D.; Nixon, D.; Picciano, M.F.; Rivlin, R.; Simopoulos, A.; Wargovich, M.J.; Weisburger, E.K.; Zeisel, S.H. The role of dietary supplements during cancer therapy. J. Nutr., 2003, 133(11 Suppl 1), 3794S-3799S.
193. Yam, D.; Peled, A.; Shinitzky, M. Suppression of tumor growth and metastasis by dietary fish oil combined with vitamins E and C and cisplatin. Cancer Chemother. Pharmacol., 2001, 47(1), 34-40.
194. Kagan, V.E.; Bayir, A.; Bayir, H.; Stoyanovsky, D.; Borisenko, G.G.; Tyurina, Y.Y.; Wipf, P.; Atkinson, J.; Greenberger, J.S.; Chapkin, R.S.; Belikova, N.A. Mitochondria-targeted disruptors and inhibitors of cytochrome c/cardiolipin peroxidase complexes: a new strategy in anti-apoptotic drug discovery. Mol. Nutr. Food Res., 2009, 53(1), 104-114.
195. Lands, B. A critique of paradoxes in current advice on dietary lipids. Prog. Lipid Res., 2008, 47(2), 77-106.